The active metabolite of leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model

Journal of Pain

Volumn 3, Issue 5, 2002, Pages 360-368

  Sweitzer, Sarah M ^a   DeLeo, Joyce A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Astrocytes; MHC class II; Microglia; Neuropathic pain

Indexed keywords

DRUG METABOLITE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; TERIFLUNOMIDE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; ASTROCYTE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MECHANICAL STIMULATION; MICROGLIA; NEUROMODULATION; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN; PROTEIN EXPRESSION; RAT;

EID: 0036796293     PISSN: 15265900     EISSN: None     Source Type: Journal    
DOI: 10.1054/jpai.2002.125181     Document Type: Article

References (54)

1. Aley K, McCarter G, Levine J: Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci 18:7008-7014, 1998
2. Arruda JL, Colburn RW, Rickman AJ, Rutkowski MD, DeLeo JA: Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: Potential role of IL-6 in neuropathic pain. Mol Brain Res 62:228-235, 1998
3. Arruda J, Sweitzer S, Rutkowski M, DeLeo JA: Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: Possible immune modulation in neuropathic pain. Brain Res 879:216-225, 2000
4. Aschner M: Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19:269-280, 1998
5. Bechmann I, Peter S, Beyer M, Gimsa U, Nitsch R: Presence of B-7.2 (CD86) and lack of B7-1 (CD80) on myelin-phagocytosing MHC-II positive rat microglia are associated with non-destructive immunity in vivo. FASEB J 10:1096, 2001
6. Cao W, Kao P, Aoki Y, Xu JC, Shorthouse RA, Morris RE: A novel mechanism of action of the immunomodulatory drug, leflunomide: Augmentation of the immunosuppressive cytokine, TGF-β1, and suppression of the immunostimulatory cytokine, IL-2. Transplant Proc 28:3079-3080, 1996
7. Cherwinski H, Byars N, Ballaron S, Nakana BM, Yound JM, Ransom JT: Leflunomide interferes with pyrimidine nucleotide biosynthesis. Inflamm Res 44:317-322, 1995
8. Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF: Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79:163-175, 1997
9. Coyle D: Partial peripheral nerve injury leads to activation of astroglia and microglia which parallel the development of allodynic behavior. Glia 23:75-83, 1998
10. DeLeo JA, Colburn RW, in Watkins L, Maier S (eds): Cytokines and Pain: Progress in Inflammation Research. Basel, Switzerland, Birkhauser Verlag, 1999, pp 159-181
11. Ding M, Hart R, Jonakait F: Tumor necrosis factor-alpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor. J Neurobiol 28:445-454, 1995
12. Elder R, Xu X, Williams J, Gong H, Finnegan A, Chong AS: The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol 159:22-27, 1997
13. Ferroni S, Marchini C, Schubert P, Rapisarda C: Two distinct inward rectifying conductances are expressed in long term dibutyryi-cyclic-AMP treated rat cultured cortical astrocytes. FEBS Lett 267:319-325, 1995
14. Fine S, Angel R, Perry S, Epstein LG, Rothstein JD, Dewhurst S, Gelbard HA: Tumor necrosis factor alpha inhibits glutamate uptake by primary human astroctyes. J Biochem 271:15303-15306, 1996
15. Fox R: Mechanism of action of leflunomide in rheumatoid arthritis. J Rheumatol Suppl 53:20-26, 1998
16. Gadient R, Otten U: Interleukin-6 (IL-6): A molecule with both beneficial and destructive potentials. Prog Neurobiol 52:379-390, 1997
17. Hashizume H, Rutkowski M, Weinstein J, DeLeo JA: Central administration of methotrexate reduces mechanical allodynia in an animal model of radiculopathy/sciatica. Pain 87:159-169, 2000
18. Jeanjean A, Moussaoui S, Maloteaux J, Laduron PM: Interleukin-1β induces long term increase of axonally transported opioate receptors and substance P. Neuroscience 68:151-157, 1995
19. Ji R, Baba H, Brenner G, Woolf CJ: Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2:1114-1119, 1999
20. Karp H, Tillotson M, Soria J, Reich C, Wood JG: Microglial tyrosine phosphorylation systems in normal and degenerating brain. Glia 11:284-290, 1994
21. Koller H, Thiem K, Siebler M: Tumour necrosis factor-alpha increases intracellular Ca2+ and induces a depolarization in cultured astroglial cells. Brain 119:2021-2027, 1996
22. Kreutzberg G: Microglia: A sensor of pathological events in the CNS. Trends Neurosci 19:312-318, 1996
23. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL: Cytokine involvement in dynorphin-induced allodynia. Pain 84:159-167, 2000
24. Manna S, Aggarwal B: Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-KB activation and gene expression. J Immunol 162:2095-2102, 1999
25. McCluskey L, Lampson L: Local immune regulation in the central nervous system by substance P vs glutamate. J Neuroimmunol 116:136-146, 2001
26. Meller S, Dykstra C, Grzybycki D, Murphy S, Gebhart GF: The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33:1471-1478, 1994
27. Miljkovic D, Samardzic T, Stojkovic M, Stosic-Grujicic S, Popadic D, Popadic D, Trajkovic V: Leflunomide inhibits activation of inducible nitric oxide synthase in rat astrocytes. Brain Res 889:331-338, 2001
28. Milligan E, Mehmert K, Hinde J, Harvey LO, Martin D, Tracey KJ, Maier SF, Watkins LR: Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 861:105-116, 2000
29. Mladenovic V, Domljan Z, Rozman B, Jajic I, Mihajlovic D, Dordevic J, Dordevic J, Popovic M, Dimitrijevic M, Zivkovic M, Campion G, Musikic P, Low-Friedrich I, Oed C, Seifert H, Strand V: Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis: Results of a randomized, placebo-controlled, Phase II Study. Arthritis Rheum 38:1595-1603, 1995
30. Morioka T, Kalehua A, Streit W: Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia. Acta Neuropathol 83:149-157, 1992
31. Morioka T, Streit W: Expression of immunomolecules on microglial cells following neonatal sciatic nerve axotomy. J Neuroimmunol 35:21-30, 1991
32. Murphy P, Ramer M, Borthwick L, Gauldie J, Richardson PM, Bisby MA: Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 11:2243-2253, 1999
33. Popovich P, Streit W, Stokes B: Differential expression of MHC class II antigen in the contused rat spinal cord. J Neurotrauma 1993;10:37-46, 1999
34. Racke M, Ratts R, Arredono L, Perrin PJ, Lovett-Racke A: The role of costimulation in autoimmune demyelination. J Neuroimmunol 107:205-215, 2000
35. Raivich G, Bohatschek M, Kloss C, Werner A, Jones LL, Kreutzberg GW: Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 30:77-105, 1999
36. Ramer M, Murphy P, Richardson P, Bisby MA: Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 78:115-121, 1998
37. Ruffalo R, Fuerstein G, Hunter A, Poste G, Metcalf BW: Inflammatory cells and mediators in CNS disease. Harwood Academic, Netherlands, 1999
38. Sallmann S, Juttler E, Prinz S, Petersen N, Knopf U, Weiser T, Schwaninger M: Induction of interleukin-6 by depolarization of neurons. J Neurosci 20:8637-8642, 2000
39. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH: Acute inflammatory responses to mechanical lesions in the CNS: Differences between brain and spinal cord. Eur J Neurosci 11:3648-3658, 1999
40. Schubert P, Morino T, Miyazaki H, Ogata T, Nakamura Y, Marchini C, Ferroni S: Cascading glia reactions: A common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann N Y Acad Sci 903:24-33, 2000
41. Schubert P, Rudolphi K: Interfering with the pathologic activation of microglial cells and astrocytes in dementia. Alzheimer Dis Assoc Disord 12:S21-28, 1998
42. Schwartz M, Moalem G: Beneficial immune activity after CNS injury: Prospects for vaccination. J Neuroimmunol 113:185-192, 2001
43. Sheu J, Kulhanek D, Eckenstein F: Differential patterns of ERK and STAT3 phosphorylation after sciatic nerve transection in the rat. Exp Neurol 166:392-402, 2000
44. Siemasko K, Chong A, Jack H, Gong H, Williams JW, Finnegan A: Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgGl production. J Immunol 160:1581, 1998
45. Streit W, Graeber M, Kreutzberg G: Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 21:117-123, 1989
46. Streit W, Walter S, Pennell N: Reactive microgliosis. Prog Neurobiol 57:563-581, 1999
47. Sweitzer S, Colburn RW, Rukowski M, DeLeo JA: Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat. Brain Res 829:209-221, 1999
48. Sweitzer S, Martin D, DeLeo J: Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibit an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103:529-539, 2001
49. Sweitzer S, Schubert P, DeLeo J: Propentofylline, a glial modulating agent, exhibits anti-allodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Therap 297:1210-1217, 2001
50. Sweitzer S, White K, Dutta C, DeLeo JA: The differential role of spinal MHC class II and cellular adhesion molecules in inflammatory versus neuropathic pain in rodents. J Neuroimmunol 125:82-93, 2002
51. Wagner J: Is IL-6 both a cytokine and a neurotrophic factor? J Exp Med 183:2417-2419, 1996
52. Watkins L, Martin D, Ulrich P, Tracey KJ, Maier SF: Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71:225-235, 1997
53. Watkins L, Milligan E, Maier S: Glial activation: A driving force for pathological pain. Trends Neurosci 24:450-455, 2001
54. Xu X, Blinder L, Shen J, Gong H, Finnegan A, Williams JW, Chong ASF: In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-Ipr/Ipr mice. J Immunol 159:167, 1997